After Hours
There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities.
Stocks Info
As a NASDAQ listed company, APLS falls under the Healthcare sector while operating within the Biotechnology industry segment. The current market capitalization of Apellis Pharmaceuticals Inc is $2.51B. A total of 3.07 million shares were traded on the day, compared to an average of 2.59M shares.
In the most recent transaction, Sullivan Timothy Eugene sold 10,000 shares of APLS for 28.03 per share on Oct 21 ’25. After the transaction, the Chief Financial Officer now owns 110,936 company shares. In a previous transaction on Oct 21 ’25, Sullivan Timothy Eugene bought 10,000 shares at 28.03 per share.
Among the insiders who sold shares, Watson David O. disposed of 5,000 shares on Oct 16 ’25 at a per-share price of $25.22. This resulted in the General Counsel holding 113,730 shares of APLS after the transaction. In another insider transaction, Watson David O. bought 5,000 shares at $25.22 per share on Oct 16 ’25.
In spite of price targets being rarely accurate, it tends to exert some kind influence from time to time, and was often accepted by the market as having some value. In terms of 52-week highs and lows, APLS has a high of $35.72 and a low of $16.10.
As of this writing, APLS has an earnings estimate of -$0.38 per share for the current quarter. EPS was calculated based on a consensus of 11.0 estimates, with a high estimate of -$0.16 per share and a lower estimate of -$0.55. The company reported an EPS of -$0.29 in the last quarter
Balance Sheet Annually/Quarterly
The balance sheet of a company shows what assets and liabilities a company has, as well as the amount, equity investors have invested. With the help of this information, a company’s financial ratios can be calculated to give investors an overview of the company’s prospects. APLS’s latest balance sheet shows that the firm has $700.55M in Cash & Short Term Investments as of fiscal 2021. There were $210.22M in debt and $131.85M in liabilities at the time. Its Book Value Per Share was $3.17, while its Total Shareholder’s Equity was $198.66M.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for APLS is Buy with a score of 4.00.
